Technologies
-
Life Technologies appoints head of global research and development
Life Technologies announced that Alan B Sachs, MD, PhD, former vice president, exploratory and translational sciences for Merck Research Laboratories, has joined the company as head of global research and development.
Technologies | 11 April 2012
-
Agilent Technologies introduces commercial hybrid supercritical fluid/UHPLC system
The 1260 Infinity Hybrid SFC/UHPLC system delivers LC-like sensitivity over the UHPLC power range.
Technologies | 03 April 2012
-
Agilent launches next-generation pharmaceutical compliance service
The updated software enables delivery of even more reliable, secure and cost-efficient analytical instrument qualification services to the pharmaceutical industry.
Technologies | 20 March 2012
-
Agilent Technologies extends target-enrichment platform to desktop sequencers
Agilent Technologies expanded its SureSelect target-enrichment system with the HaloPlex target enrichment system for desktop sequencers.
Technologies | 12 March 2012
-
Life Technologies partners with DaAn Gene
Life Technologies announced that it has signed an agreement with DaAn Gene, a Chinese company in molecular in-vitro diagnostics (IVD), to form Life Technologies DaAn Diagnostics, a joint venture diagnostics business in China. The move is expected to contribute to the early diagnosis of oncology, infectious diseases and genetic diseases. Financial terms of the deal were not disclosed.
Technologies | 05 March 2012
-
Life Technologies plant wins award
First biotechnology plant to win IndustryWeek’s award, cited for nventory reductions, gross margin and productivity improvements, high performance teams, lean manufacturing principles and six sigma.
Technologies | 01 March 2012
-
Agilent Technologies introduces DNA methylation target-enrichment system
Agilent Technologies expanded its target-enrichment platform with the SureSelect XT Human Methyl-Seq system for epigenetic research into DNA methylation sites. It is the first comprehensive DNA methylation discovery system using target enrichment.
Technologies | 27 February 2012
-
Genetic Technologies receives CLIA certificate of compliance from Centers for Medicare and MedicAid Services, USA
Genetic Technologies announced that it has received the Certificate of Compliance for its Australian laboratory under the US Clinical Laboratories Improvements Amendments (CLIA) regulations as administered by the Centers for Medicare and Medicaid Services (CMS).
Technologies | 21 February 2012
-
Agilent Technologies replaces signal-to-noise spec for triple quadrupole GC/MS
Agilent Technologies announced that it is replacing the signal-to-noise specification with a instrument detection limit specification for its 7000B triple quadrupole gas chromatography/mass spectrometry system.
Technologies | 16 February 2012
-
Life Technologies appoints president of medical sciences
Life Technologies announced that Ronnie Andrews, former CEO of Clarient and Segment Leader, GE Molecular Diagnostics, has joined the company as president, medical sciences.
Technologies | 10 February 2012
